Clinical Trial Update: Phase Ib Study to Assess Safety and Preliminary Efficacy of Tafasitamab or Tafasitamab Plus Lenalidomide in Addition to R-CHOP in Patients With Newly Diagnosed DLBCL [Phase 1]

View source ↗

Summary

Phase Ib trial assessing safety and preliminary efficacy of tafasitamab alone or with lenalidomide added to R-CHOP in newly diagnosed Diffuse Large B-Cell Lymph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Monjuvi (tafasitamab)
• Revlimid (lenalidomide)

Snippet

Sponsor: MorphoSys AG | Conditions: Diffuse Large B-cell Lymphoma | Phase 1 | Status: COMPLETED | Results posted: 2024-10-16